Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_37f4922dfb7777b019e504b885211b8e http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c930c1a3fcc9a93dc304ab4a77bd0ea3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d4005cb3abf2f1b2e54b77efb90c0025 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-136 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2525-155 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2545-114 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6855 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-703 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-70 |
filingDate |
2013-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d4a692239d31e37006ca068d5c3b44d0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b5715778aa20161f590dce494b23aaf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b87f0a6430cb2a70db1221032a47a9f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d884a660145c7ac159d952083a2d298 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_073b9642e5dfbb783cf2e56a8266ae0d |
publicationDate |
2013-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2013186718-A1 |
titleOfInvention |
Method for quantifying different viral forms of the dna of the hiv virus |
abstract |
The invention relates to a method for quantifying linear forms of the DNA genome of the human immunodeficiency virus 1 (HIV-1) in a sample, wherein: a ligation reaction is performed with a double-stranded oligonucleotide suitable for ligation with the linear form of the HIV-1 DNA genome having a mature 3' end and/or the linear form of the HIV-1 DNA genome having a non-mature 3' end; a quantitative PCR is carried out from the ligation product obtained in the previous step; and the quantity of the linear form of the HIV-1 DNA genome having a mature 3' end and/or the quantity of the linear form of the HIV-1 DNA genome having a non-mature 3' end in the sample are deduced therefrom. |
priorityDate |
2012-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |